A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides
NCT07714187 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-07-20
Summary
This study will evaluate the safety and preliminary efficacy of duvelisib topical gel in participants with early-stage mycosis fungoides.
Conditions
- Mycosis Fungoides
- Cutaneous T-cell Lymphoma
Interventions
- DRUG
-
Duvelisib
Topical gel
Sponsors & Collaborators
-
SecuraBio
lead INDUSTRY
Principal Investigators
-
Reuven Chantre, MD · Secura Bio, Inc.
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2027-01-31
- Primary Completion
- 2028-10-31
- Completion
- 2029-01-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
NCT04911751 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis
NCT01412944 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis
NCT03504852 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06411379 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
NCT06345404 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02445807 ·Status: COMPLETED ·Phase: PHASE3
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT03274076 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
NCT02931838 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT04785326 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BMS-587101 in Patients With Moderate to Severe Psoriasis
NCT00162253 ·Status: TERMINATED ·Phase: PHASE2
-
Immunologic Response to Secukinumab in Plaque Psoriasis
NCT02592018 ·Status: COMPLETED ·Phase: PHASE4
-
4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
NCT01640951 ·Status: COMPLETED ·Phase: PHASE3
-
A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)
NCT02394561 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
NCT04242498 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study
NCT02413229 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02635204 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT05620823 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
NCT04242446 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
NCT05478499 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)
NCT06687967 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis
NCT00001797 ·Status: COMPLETED ·Phase: PHASE2
-
A Study In Adults With Moderate To Severe Dermatomyositis
NCT03181893 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients
NCT01537432 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AK111 in Healthy Subjects
NCT03622021 ·Status: COMPLETED ·Phase: PHASE1